Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia. Academic Article uri icon

Overview

abstract

  • Several chronic lymphocytic leukaemia (CLL) susceptibility loci have been reported; however, much of the heritable risk remains unidentified. Here we perform a meta-analysis of six genome-wide association studies, imputed using a merged reference panel of 1,000 Genomes and UK10K data, totalling 6,200 cases and 17,598 controls after replication. We identify nine risk loci at 1p36.11 (rs34676223, P=5.04 × 10-13), 1q42.13 (rs41271473, P=1.06 × 10-10), 4q24 (rs71597109, P=1.37 × 10-10), 4q35.1 (rs57214277, P=3.69 × 10-8), 6p21.31 (rs3800461, P=1.97 × 10-8), 11q23.2 (rs61904987, P=2.64 × 10-11), 18q21.1 (rs1036935, P=3.27 × 10-8), 19p13.3 (rs7254272, P=4.67 × 10-8) and 22q13.33 (rs140522, P=2.70 × 10-9). These new and established risk loci map to areas of active chromatin and show an over-representation of transcription factor binding for the key determinants of B-cell development and immune response.

authors

publication date

  • February 6, 2017

Research

keywords

  • Antibody Formation
  • Chromosomes, Human
  • Genetic Predisposition to Disease
  • Leukemia, Lymphocytic, Chronic, B-Cell

Identity

PubMed Central ID

  • PMC5303820

Scopus Document Identifier

  • 85012025522

Digital Object Identifier (DOI)

  • 10.1038/ncomms14175

PubMed ID

  • 28165464

Additional Document Info

volume

  • 8